Cancer Centers Unite to Launch Immunotherapy Program
Dr. Bobby Lazzara discusses the recent announcement of the Parker Institute for Cancer Immunotherapy.
Thanks to a $250 million grant from The Parker Foundation, the cancer Moonshot initiative just got a boost to help create the Parker Institute for Cancer Immunotherapy.
The Parker Institute includes six cancer centers: University of California San Francisco (UCSF), Memorial Sloan Kettering Cancer Center, Stanford Medicine, University of California, Los Angeles (UCLA), the University of Pennsylvania, and The University of Texas MD Anderson Cancer Center.
The goal of this program is to accelerate the development of immunotherapies with the help of approximately 300 researchers in over 40 laboratories. Each of the designated centers will receive initial funding and will continue to grow from various other grants over time.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Building Efficiency and Scaling With a Remote Genetic Counseling Program
Smita K. Rao, MBBS, MS, et al gave an overview of implementing genetic counseling into oncology practices through telemedicine.
Nurse-Led Program May Increase Germline Testing in Black Veterans With Cancer
June 1st 2023The association between use of a telegenetics service and lower likelihood of germline testing was statistically significant among black veterans with cancer, according to a recent retrospective cohort study.
New NSCLC Treatment Options Needed to Successfully Target Multiple Gene Changes
November 24th 2017Researchers analyzed samples from 1,122 patients with advanced-stage NSCLC and discovered that 92.9% of tumors from harbored multiple changes in cancer-related genes in addition to the EGFR driver mutation.
